It has been almost a year since the initial launch of Version One Ventures and…
Version One
While crunching the data and reflecting on the past year, it’s clear that 2012 was busy. Version One Ventures made eleven investments, including three angel investments that rolled over into the fund. Here are some of the more interesting details to share about our activity in 2012: Version One invested more than $2.5M in 2012 […]
It has been almost a year since the initial launch of Version One Ventures and…
Imagine a future, maybe 20-25 years from now, when there’s a smart toilet in every…
While crunching the data and reflecting on the past year, it’s clear that 2012 was busy. Version One Ventures made eleven investments, including three angel investments that rolled over into the fund.
Here are some of the more interesting details to share about our activity in 2012:
Announcing Version One’s final close
In addition to wrapping up 2012, I’m happy to announce the final close of the Version One Ventures fund with $19 million in committed capital. Our original target was $10M, so I’m extremely grateful at the confidence our investors placed in the fund. In addition, I’m particularly excited that this final close includes an institutional investor, the Business Development Bank of Canada (BDC) – their announcement can be found here.
Moving forward, we’re continuing our focus on e-commerce, SaaS, and marketplace opportunities in the Seed or Series A stages. It is still early times for the web and we’re excited to work with great entrepreneurs looking to change their industry or the world.
Health / Biology, Portfolio, Version One
Shifting healthcare systems from reactive to proactive care is critical – the best outcomes occur when people can take action early, before a condition becomes a diagnosis. That’s why we are excited to announce that we have led a $2.5m pre-seed round for NiaHealth and are thrilled that they are coming out of stealth and […]
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and…
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have…